Combination of multiple mRNA markers (PTTG1, survivin, UbcH10 and TK1) in the diagnosis of Taiwanese patients with breast cancer by membrane array

被引:73
作者
Chen, Chung-Chi
Chang, Tsai-Wang
Chen, Fang-Ming
Hou, Ming-Feng
Hung, Sung-Yu
Chong, Inn-Wen
Lee, Su-Chen
Zhou, Tian-Hong
Lin, Shiu-Ru
机构
[1] Kaohsiung Med Univ, MedicoGenom Res Ctr, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Dept Surg, Kaohsiung 807, Taiwan
[3] Kaohsiung Med Univ, Dept Internal Med, Kaohsiung 807, Taiwan
[4] Kaohsiung Med Univ, Dept Lab Med, Kaohsiung Med Univ Hosp, Kaohsiung 807, Taiwan
[5] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung 807, Taiwan
[6] Kaohsiung Med Univ, Grad Med Genet, Coll Med, Kaohsiung 807, Taiwan
[7] Sung Hua Gene Co Ltd, Kaohsiung, Taiwan
[8] Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med & Clin Labs, Kaohsiung, Taiwan
[9] Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70428, Taiwan
[10] Jinan Univ, Dept Biotechnol, Guangzhou, Peoples R China
关键词
breast cancer; mRNA expression; tumor marker; circulating tumor cells; membrane array;
D O I
10.1159/000098557
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Early detection is a prerequisite to the effective reduction of morbidity and mortality from breast cancer. The present study intended to employ a high-throughput membrane array to detect a panel of mRNA markers expressed by circulating tumor cells (CTCs) in the peripheral blood of female patients with breast cancer. Methods: Peripheral blood was sampled from 92 breast cancer patients and 100 normal persons. CTCs were detected by using a membrane array technique. The markers used included the pituitary tumor transforming gene 1, survivin, UbcH10 and thymidine kinase 1. Results: The results showed that the membrane array could positively detect 5 cancer cells per 1 ml of peripheral blood in breast cancer cell dilution experiments. For the panel of 4 mRNA markers, sensitivity and specificity were elevated up to 86 and 88%, respectively. Furthermore, it was found that the patients' clinicopathological characteristics tumor size (p = 0.006), histologic grade (p = 0.012), lymph node metastasis (p = 0.001) and TNM stage (p = 0.006) significantly correlated with the positive detection rate of the multimarker panel. Conclusions: These findings demonstrated that our multimarker membrane array method could detect CTCs in the circulation of breast cancer patients with considerably high sensitivity and specificity. Copyright (c) 2006 S. Karger AG, Basel
引用
收藏
页码:438 / 446
页数:9
相关论文
共 41 条
[1]   Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer.: Comparison of CK19, MUC1 and CEA using RT-PCR [J].
Berois, N ;
Varangot, M ;
Aizen, B ;
Estrugo, R ;
Zarantonelli, L ;
Fernández, P ;
Krygier, G ;
Simonet, F ;
Barrios, E ;
Musé, L ;
Osinaga, E .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (06) :717-723
[2]   Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients [J].
Bostick, PJ ;
Chatterjee, S ;
Chi, DD ;
Huynh, KT ;
Giuliano, AE ;
Cote, R ;
Hoon, DSB .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2632-2640
[3]   Thymidine kinase as a proliferative marker:: Clinical relevance in 1,692 primary breast cancer patients [J].
Broët, P ;
Romain, S ;
Daver, A ;
Ricolleau, G ;
Quillien, V ;
Rallet, A ;
Asselain, B ;
Martin, PM ;
Spyratos, F .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) :2778-2787
[4]   Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells [J].
Burchill, SA ;
Lewis, IJ ;
Selby, P .
BRITISH JOURNAL OF CANCER, 1999, 79 (5-6) :971-977
[5]   Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis [J].
Chen, Chung-Chi ;
Hou, Ming-Feng ;
Wang, Jaw-Yuan ;
Chang, Tsai-Wang ;
Lai, Dan-Yu ;
Chen, Yi-Fang ;
Hung, Sung-Yu ;
Lin, Shiu-Ru .
CANCER LETTERS, 2006, 240 (02) :279-288
[6]   Detection of circulating cancer cells with K-ras oncogene using membrane array [J].
Chen, YF ;
Wang, JY ;
Wu, CH ;
Chen, FM ;
Cheng, TL ;
Lin, SR .
CANCER LETTERS, 2005, 229 (01) :115-122
[7]   Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use? [J].
Conzelmann, M ;
Linnemann, U ;
Berger, MR .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2005, 20 (02) :137-146
[8]   Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples [J].
Cruz, I ;
Ciudad, J ;
Cruz, JJ ;
Ramos, M ;
Gómez-Alonso, A ;
Adansa, JC ;
Rodríguez, C ;
Orfao, A .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 123 (01) :66-74
[9]   SENSITIVE DETECTION OF OCCULT BREAST-CANCER BY THE REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION [J].
DATTA, YH ;
ADAMS, PT ;
DROBYSKI, WR ;
ETHIER, SP ;
TERRY, VH ;
ROTH, MS .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) :475-482
[10]   The case for early detection [J].
Etzioni, R ;
Urban, N ;
Ramsey, S ;
McIntosh, M ;
Schwartz, S ;
Reid, B ;
Radich, J ;
Anderson, G ;
Hartwell, L .
NATURE REVIEWS CANCER, 2003, 3 (04) :243-252